EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review

Fabian O Lurquin iD, Michel P Hermans, Sophie Gohy, Vanessa Preumont

Endocrine Connections · 01.11.2025 · 14 (11)

DOI: 10.1530/ec-25-0135 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Connections, online erschienen am 21.10.2025. Verfasst von Fabian O Lurquin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graphical Abstract Abstract Alongside pulmonary and nutritional benefits, highly effective modulator therapies (HEMT) can promote an increase in body fat and raise the prevalence of overweight/obesity, dyslipidemia, and hypertension in patients with cystic fibrosis. These metabolic changes will theoretically elevate cardiovascular risk in a population that has largely been unaffected by such complications until now. A rise in the prevalence of metabolic syndrome among HEMT-treated patients is expected, which has already prompted a review of dietary recommendations. Thus, a distinction must be made between patients with several years of care experience and those, especially younger patients or those with a late diagnosis of cystic fibrosis, who have not been educated on the principle of a high-calorie diet. Whether these metabolic changes will result in a greater incidence of cardiovascular events remains uncertain, underscoring the need to validate predictive risk scores in this context.

Schlagwörter

Stichwörter der Autor:innen

cardiovascularcystic fibrosishighly effective modulator therapymetabolic syndrome

Autor:innen und Institutionen

  • Department of Endocrinology and Nutrition, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Endocrinology, Diabetes, Nutrition Pole (EDIN), Institut de recherche expérimentale et clinique, (IREC), UCLouvain, Brussels, Belgium.
  • Department of Pneumology, CF Reference Centre, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Lung, Nose, Skin Pole (LUNS), Institut de recherche expérimentale et clinique, (IREC), UCLouvain, Brussels, Belgium.

ORCID-Profile: Fabian O Lurquin

Zitieren

APA

Lurquin, F. O., Hermans, M. P., Gohy, S., & Preumont, V. (2025). Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review. Endocrine Connections, 14(11). https://doi.org/10.1530/ec-25-0135

Vancouver

Lurquin FO, Hermans MP, Gohy S, Preumont V. Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review. Endocrine Connections. 2025;14(11). doi:10.1530/ec-25-0135

BibTeX
@article{Lurquin2025,
  author = {Lurquin, Fabian O and Hermans, Michel P and Gohy, Sophie and Preumont, Vanessa},
  title = {Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review},
  journal = {Endocrine Connections},
  year = {2025},
  volume = {14},
  number = {11},
  doi = {10.1530/ec-25-0135}
}
Kostenlos starten →